Calyxt, Inc. (CLXT)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Calyxt, Inc. (CLXT) trades at $6.30 with AI Score 43/100 (Grade C). Calyxt, Inc. focuses on delivering plant-based solutions to the agriculture market. The company develops improved digestibility alfalfa, hemp, and wheat with higher fiber content. Market cap: $31.33M, Sector: Consumer defensive.
Price live · AI analysis from May 10, 2026Analyst Coverage for CLXT: CLXT does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CLXT against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CLXT: the 1 perspectives are evenly split.
How is this calculated? →Calyxt, Inc. (CLXT) Consumer Business Overview
Calyxt, Inc., a synthetic biology company, delivers plant-based solutions to the agriculture market, focusing on improved digestibility alfalfa, hemp, and high-fiber wheat. Their commercial agreement with S&W Seed Company enhances market reach, positioning them within the evolving landscape of agricultural biotechnology.
What Is the Investment Thesis for CLXT?
Calyxt, Inc. presents a compelling, albeit high-risk, investment thesis centered on its innovative approach to plant-based solutions in the agriculture sector. The company's focus on developing crops with improved traits, such as enhanced digestibility alfalfa and high-fiber wheat, addresses growing consumer demand for healthier and more sustainable food options. A key value driver is the commercialization agreement with S&W Seed Company, providing Calyxt with access to established distribution channels and market expertise. However, with a profit margin of -3492.3% and a market capitalization of $31.33M, the company's financial stability is a significant concern. The high beta of 2.04 indicates substantial volatility, reflecting the speculative nature of the stock. Successful execution of its commercialization strategy and achieving profitability are critical for Calyxt to deliver long-term value.
Based on FMP financials and quantitative analysis
CLXT Key Highlights
- Calyxt operates in the synthetic biology space, focusing on plant-based solutions for the agriculture market.
- The company's lead product is improved digestibility alfalfa, aimed at enhancing animal feed efficiency.
- Calyxt has a commercialization agreement with S&W Seed Company for its improved quality alfalfa seed.
- The company's profit margin is -3492.3%, indicating significant losses.
- Calyxt's market capitalization is $0.03 billion, reflecting its small size and potential volatility.
Who Are CLXT's Competitors?
CLXT is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SW Smurfit Westrock Plc | $45.77 | -0.35% | $24.00B | 53 |
| GPAGF Gruma, S.A.B. de C.V. | $18.50 | +2.21% | $6.31B | 66 |
| PNGAF Pangea Wellness Inc. | $0.37 | +10.51% | $5.54M | 65 |
| ZHYBF Zhong Yuan Bio-Technology Holdings Limited | $2.02 | +0.00% | $35.75M | 64 |
| BOF BranchOut Food Inc. | $4.58 | -4.18% | $70.15M | 61 |
| WESTW Westrock Coffee Company, LLC | $1.92 | +29.73% | $168.42M | 51 |
| PTCXF PT Wilmar Cahaya Indonesia Tbk. | $0.11 | +0.00% | $70.48M | 51 |
| DAR Darling Ingredients Inc. | $57.49 | +1.70% | $9.14B | 51 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CLXT's Key Strengths?
- Proprietary gene editing technology
- Focus on sustainable agriculture
- Commercialization agreement with S&W Seed Company
What Are CLXT's Weaknesses?
- Significant losses and negative profit margin
- Small market capitalization
- Dependence on a limited number of products
What Could Drive CLXT Stock Higher?
- Expansion of commercial sales of improved digestibility alfalfa through S&W Seed Company distribution network.
- Potential regulatory approvals for new genetically modified crop varieties.
- Development and introduction of new hemp varieties with improved traits.
What Are the Key Risks for CLXT?
- Financial-distress signal — its Altman Z-Score of -3.99 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Significant losses and negative profit margin pose a financial risk.
- Regulatory hurdles and consumer resistance to genetically modified crops could hinder commercialization.
- Competition from established agricultural companies could limit market share.
What Are the Growth Opportunities for CLXT?
- Growth opportunity 1: Expanding the commercialization of improved digestibility alfalfa through the partnership with S&W Seed Company represents a significant growth opportunity. The alfalfa market is substantial, with a global market size estimated at several billion dollars. By leveraging S&W Seed Company's distribution network, Calyxt can increase its market penetration and capture a larger share of the alfalfa seed market. The timeline for this growth is ongoing, as the company continues to expand its distribution and marketing efforts. A competitive advantage lies in the improved digestibility of Calyxt's alfalfa, which can lead to increased animal feed efficiency and reduced environmental impact.
- Growth opportunity 2: Developing and commercializing hemp varieties with improved traits offers another growth avenue for Calyxt. The hemp market is experiencing rapid growth, driven by increasing demand for hemp-based products in various industries, including food, textiles, and pharmaceuticals. The global hemp market is projected to reach billions of dollars in the coming years. Calyxt's expertise in plant genetics and gene editing can enable it to develop hemp varieties with higher yields, improved fiber quality, and enhanced cannabinoid profiles. The timeline for this growth is within the next few years, as the company progresses through research and development and regulatory approvals. A competitive advantage lies in Calyxt's ability to develop proprietary hemp varieties with unique characteristics.
- Growth opportunity 3: Introducing wheat varieties with higher fiber content presents a growth opportunity in the consumer food market. Consumers are increasingly seeking healthier food options, including those with higher fiber content. The market for high-fiber foods is substantial, with a global market size estimated at billions of dollars. Calyxt's wheat varieties can be used to produce a range of food products, such as bread, pasta, and cereals, with improved nutritional profiles. The timeline for this growth is within the next few years, as the company conducts field trials and seeks regulatory approvals. A competitive advantage lies in Calyxt's ability to develop wheat varieties with significantly higher fiber content compared to traditional varieties.
- Growth opportunity 4: Leveraging its expertise in gene editing technology to develop other improved crop varieties represents a long-term growth opportunity for Calyxt. The company can apply its technology to a wide range of crops, addressing various agricultural challenges and consumer needs. The market for genetically modified crops is substantial, with a global market size estimated at tens of billions of dollars. Calyxt can focus on developing crops with improved yields, pest resistance, drought tolerance, and nutritional content. The timeline for this growth is over the next several years, as the company continues to invest in research and development and expands its product pipeline. A competitive advantage lies in Calyxt's proprietary gene editing technology and its ability to develop innovative crop varieties.
- Growth opportunity 5: Expanding its geographic reach beyond the United States represents a growth opportunity for Calyxt. The company can target international markets with its improved crop varieties, addressing agricultural challenges and consumer needs in different regions. The global market for agricultural biotechnology is substantial, with significant growth potential in developing countries. Calyxt can partner with local companies and distributors to enter new markets and adapt its products to local conditions. The timeline for this growth is over the next several years, as the company conducts market research and establishes international partnerships. A competitive advantage lies in Calyxt's ability to develop crop varieties that are tailored to specific regional needs and environmental conditions.
What Opportunities Does CLXT Have?
- Expanding commercialization of improved alfalfa
- Developing and commercializing hemp varieties
- Introducing wheat varieties with higher fiber content
What Threats Does CLXT Face?
- Regulatory hurdles for genetically modified crops
- Consumer resistance to genetically modified organisms
- Competition from established agricultural companies
What Are CLXT's Competitive Advantages?
- Proprietary gene editing technology.
- Commercialization agreement with S&W Seed Company.
- Focus on developing crops with improved traits.
What Does CLXT Do?
Calyxt, Inc., established in 2010 and headquartered in Roseville, Minnesota, is a synthetic biology company dedicated to providing plant-based solutions to the agriculture industry. Originally named Cellectis Plant Sciences, Inc., the company rebranded to Calyxt, Inc. in May 2015 to reflect its focus on leveraging plant genetics to create healthier and more sustainable food sources. As a subsidiary of Cellectis S.A., Calyxt benefits from a foundation in gene editing technology, which it applies to develop crops with improved traits. The company's primary focus is on developing and commercializing crops with enhanced characteristics, including improved digestibility alfalfa, hemp, and wheat with higher fiber content. These crops are designed to offer benefits to both farmers and consumers, such as increased yields, reduced input costs, and improved nutritional profiles. Calyxt's lead product is its improved digestibility alfalfa, which aims to enhance animal feed efficiency and reduce environmental impact. The company has a commercialization agreement with S&W Seed Company for the exclusive license of this improved quality alfalfa seed in the United States and internationally, expanding its market reach and distribution capabilities. Calyxt's strategic focus on synthetic biology and plant-based solutions positions it within the broader trend of sustainable agriculture and healthier food choices.
What Products and Services Does CLXT Offer?
- Develops plant-based solutions for the agriculture market.
- Focuses on improving crop traits through synthetic biology.
- Creates alfalfa with enhanced digestibility for animal feed.
- Develops hemp varieties with improved characteristics.
- Produces wheat with higher fiber content for healthier food products.
- Partners with S&W Seed Company for commercialization of alfalfa seed.
How Does CLXT Make Money?
- Develops and licenses improved crop varieties.
- Generates revenue through commercialization agreements.
- Focuses on plant genetics and gene editing technologies.
What Industry Does CLXT Operate In?
Calyxt, Inc. operates within the packaged foods industry, which is part of the broader consumer defensive sector. This sector is generally considered stable, as demand for food products remains relatively constant regardless of economic conditions. However, Calyxt's focus on synthetic biology and genetically modified crops places it in a niche segment with higher growth potential but also greater regulatory and consumer acceptance risks. The competitive landscape includes both traditional agricultural companies and other biotechnology firms developing improved crop varieties. Calyxt's success depends on its ability to differentiate its products through superior performance and nutritional benefits, as well as navigating the complex regulatory environment for genetically modified organisms.
Who Are CLXT's Key Customers?
- Farmers seeking improved crop yields and reduced input costs.
- Animal feed producers looking for enhanced feed efficiency.
- Food companies seeking healthier and more sustainable ingredients.
Key Financial Metrics
Return on assets is -31.5%, showing how much profit it generates from its asset base. A current ratio of 2.37 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -2.5%, the inverse of the P/E and a quick read on earnings relative to price.
How Calyxt, Inc. Is Valued
Calyxt, Inc. carries a market capitalization of $31.33M, placing it in the micro-cap category. Relative to its peer group, CLXT's quantitative score of 43/100 is below the peer average of 62/100.
F-Score 3/9Financial Health
Calyxt, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -3.99 places it in the distress zone, a signal of elevated financial risk.
CLXT Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Calyxt's future growth, indicating that key stakeholders believe in the company's potential.
- Community sentiment has shifted positively, with discussions highlighting the innovative nature of Calyxt's plant-based products and their relevance in a growing market.
- The company's recent partnerships in agriculture technology have sparked interest, positioning Calyxt as a leader in sustainable practices.
- Market perception is bolstered by increasing consumer demand for plant-based alternatives, aligning with Calyxt's mission.
Bear Case
- Concerns about the company's ability to scale production effectively have emerged, leading to skepticism among some investors.
- Recent social media discussions indicate a lack of clarity regarding Calyxt's long-term profitability, raising doubts about its financial sustainability.
- Some community members express frustration over the slow pace of product rollout, which could hinder competitive positioning in a fast-evolving market.
- Market perception is challenged by broader economic conditions, with uncertainty affecting investor sentiment towards growth-focused companies.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CLXT Latest News
No recent news available for CLXT.
CLXT Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLXT.
Price Targets
Wall Street price target analysis for CLXT.
CLXT MoonshotScore
What does this score mean?
The MoonshotScore rates CLXT's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Michael Allen Carr
Chief Executive Officer
Michael Allen Carr serves as the Chief Executive Officer of Calyxt, Inc. His background includes extensive experience in the agricultural and biotechnology industries. Carr's expertise spans strategic planning, business development, and commercial operations. He is responsible for guiding Calyxt's overall strategy and execution, focusing on delivering plant-based solutions to the agriculture market. His leadership is crucial for driving the company's growth and achieving its financial goals.
Track Record: Under Michael Allen Carr's leadership, Calyxt has focused on developing and commercializing improved crop varieties, including alfalfa, hemp, and wheat. He has overseen the company's commercialization agreement with S&W Seed Company for alfalfa seed. Carr's strategic decisions aim to position Calyxt as a leader in sustainable agriculture and healthier food choices. However, the company's financial performance remains a challenge, with significant losses and a small market capitalization.
What Investors Ask About Calyxt, Inc. (CLXT) — Consumer Defensive
What does Calyxt, Inc. do?
Calyxt, Inc. is a synthetic biology company focused on developing and commercializing plant-based solutions for the agriculture market. The company uses gene editing technology to create crops with improved traits, such as enhanced digestibility alfalfa, hemp, and wheat with higher fiber content. Calyxt's products aim to offer benefits to farmers, food companies, and consumers by increasing yields, reducing input costs, and improving nutritional profiles. The company partners with S&W Seed Company for the commercialization of its alfalfa seed, expanding its market reach and distribution capabilities.
What do analysts say about CLXT stock?
Given Calyxt's small market capitalization of $31.33M and negative profit margin of -3492.3%, analyst coverage may be limited. Any analyst reports would likely focus on the company's growth potential in the agricultural biotechnology market, its commercialization strategy, and its ability to achieve profitability. Key valuation metrics would include revenue growth, gross margin, and cash flow. However, the high beta of 2.04 indicates substantial volatility, reflecting the speculative nature of the stock. Investors should carefully consider the risks and uncertainties associated with Calyxt's financial performance and regulatory environment.
What are the main risks for CLXT?
Calyxt faces several significant risks, including its financial performance, regulatory environment, and competition. The company's negative profit margin and small market capitalization raise concerns about its financial stability and ability to fund its operations. Regulatory hurdles and consumer resistance to genetically modified crops could hinder the commercialization of its products. Competition from established agricultural companies and other biotechnology firms could limit its market share. Additionally, the company's dependence on a limited number of products and its partnership with S&W Seed Company expose it to concentration risk.
What are the key factors to evaluate for CLXT?
Calyxt, Inc. (CLXT) holds an AI score of 43/100 (low). Not financial advice.
How frequently does CLXT data refresh on this page?
CLXT prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CLXT's recent stock price performance?
Calyxt, Inc. (CLXT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Proprietary gene editing technology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CLXT overvalued or undervalued right now?
Valuing Calyxt, Inc. (CLXT) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CLXT?
Before investing in Calyxt, Inc. (CLXT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data may be outdated.
- Analyst coverage may be limited.